Lp(a) in chronic kidney disease: state of the art and management perspectives
Journal of Nephrology · 2026
DOI: 10.1093/joneph/aajag084 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Nephrology, 2026. Verfasst von Leonardo Spatola und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology and Dialysis, Ospedale Sant' Antonio Abate, AspTrapani, via Cosenza, Erice, TP, Italy. Hauptthemen laut MEDLINE: Lipoprotein(a), Renal Insufficiency, Chronic, Dyslipidemias, Cardiovascular Diseases. Die Arbeit nennt 51 Literaturangaben.
Abstract (Originalsprache)
Patients with chronic kidney disease (CKD) exhibit a higher cardiovascular risk compared to the general population, due to CKD itself and its associated metabolic disorders, such as dyslipidemia. While statin-based management is the current gold standard therapy for dyslipidemia in mild to moderate CKD patients, it has a limited effect on lipoproteins, other than low density lipoproteins such as Lp(a). This limitation should be taken into consideration in cardiovascular risk stratification. Furthermore, statin therapy has not shown any beneficial effects in dialysis patients without prior cardiovascular disease, leading to uncertainty regarding the optimal dyslipidemia management in kidney failure (KF) patients. In this context, high serum Lp(a) levels (>105 nmol/L) should be acknowledged as a significant cardiovascular risk factor due to their pro-atherosclerotic and pro-calcific effects. However, selective Lp(a)-lowering therapies are still lacking in current clinical practice, although novel therapies are emerging in promising Phase III randomized trials. This narrative review summarizes the role of Lp(a) in CKD and discusses current state of the art and future therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nephrology and Dialysis, Ospedale Sant' Antonio Abate, AspTrapani, via Cosenza, Erice, TP, Italy.
- Division of Nephrology and Dialysis, Ospedale Cannizzaro, Via Messina, Catania, CT, Italy.
- Division of Nephrology and Dialysis, Ospedale "Carlo Urbani", Jesi, AN, Italy.
ORCID-Profile: Leonardo Spatola, Rosario Maccarrone
Zitieren
APA
Spatola, L., Maccarrone, R., Zeiler, M., & Granata, A. (2026). Lp(a) in chronic kidney disease: state of the art and management perspectives. Journal of Nephrology. https://doi.org/10.1093/joneph/aajag084
Vancouver
Spatola L, Maccarrone R, Zeiler M, Granata A. Lp(a) in chronic kidney disease: state of the art and management perspectives. Journal of Nephrology. 2026. doi:10.1093/joneph/aajag084
BibTeX
@article{Spatola2026,
author = {Spatola, Leonardo and Maccarrone, Rosario and Zeiler, Matthias and Granata, Antonio},
title = {Lp(a) in chronic kidney disease: state of the art and management perspectives},
journal = {Journal of Nephrology},
year = {2026},
doi = {10.1093/joneph/aajag084}
}
EUVIMED